Media Room
latest news
AMR life sciences industry 2020 report: Successes and setbacks in fighting superbugs
AMR Industry Alliance reports breakthroughs in the responsible manufacturing of antibiotics and positive steps to improve how patients access and use antibiotics. But its report also highlights conc...
Read more
AMR Industry Alliance Round-Up, Issue No.3, November 2019
Welcome to the third issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as p...
Read more
AMR Industry Alliance Round-Up, Issue No.2, September 2019
Welcome to the second issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as...
Read morefrom the blog
US FDA report finds economic forces at the root of generic antibiotic shortages
Generic antibiotics underpin recommended prescribing guidance for most infections, accounting for between 80% and 90% of prescriptions in primary healthcare worldwide. However, increasing costs and in...
Read more
The new reality for next-gen antibiotics
The future of antibiotic development lies in targeted approaches that can deliver novel drugs tailored to tackle those highly resistant pathogens with greatest medical need. The world of antibacte...
Read more
Putting the brakes on AMR in India
India’s ban on colistin in the animal food industry marks a critical move against AMR in the country; one that should go hand in hand with a stringent crackdown on inappropriate use in human medicin...
Read morein the press
The Fight Against Superbugs: Properly Incentivising Antimicrobial R&D Is Key
This article was published in Pharma Boardroom on 16 January 2020. Opinion by Greg Frank. Drug-resistant superbugs are evolving at a rapid pace. In fact, it is estimated that 700,000 people die fr...
Read more
Opinion: How to oppose the menace of antimicrobial resistance
This article was published in Devex 20 January 2020. Opinion by Serufusa Sekidde. Despite its magnitude, lack of access to antibiotics is a largely overlooked public health issue. 5.7 million peop...
Read more
Low Antibiotic Prices Dampen Industry Investment In Vital New Tools To Combat Superbugs – Says AMR Industry Alliance
This article was published in Health Policy Watch 16 January 2020 by Elaine Ruth Fletcher The low worldwide prices for antibiotics, combined with the need to carefully ration sale of any powerful n...
Read more